BL-B01D1

(Synonyms: Izalontamab Brengitecan)
Kundenbewertung

Based on 1 Customer Validation

BL-B01D1 is a bispecific ADC, which targets EGFR and HER3 through bispecific antibody Izalontamab (HY-P99676), and exhibits cytotoxicity against various cancer cells via inhibition of DNA replication and DNA synthesis by its ADC toxin ED04 (HY-153891). BL-B01D1 can be used in the study of cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.65%
  • Molecular Weight:205830.00
  • Speicherung:

    -80°C, protect from light

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle EGFR Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00